Skip to main content

Sources of pre-analytical variations in yield of DNA extracted from blood samples: analysis of 50,000 DNA samples in EPIC.

Caboux E, Lallemand C, Ferro G, Hémon B, Mendy M, Biessy C, Sims M, Wareham N, Britten A, Boland A, Hutchinson A, Siddiq A, Vineis P, Riboli E, Romieu I, Rinaldi S, Gunter MJ, Peeters PH, van der Schouw YT, Travis R, Bueno-de-Mesquita HB, Canzian F, Sánchez MJ, Skeie G, Olsen KS, Lund E, Bilbao R, Sala N, Barricarte A, Palli D, Navarro C, Panico S, Redondo ML, Polidoro S, Dossus L, Boutron-Ruault MC, Clavel-Chapelon F, Trichopoulou A, Trichopoulos D, Lagiou P, Boeing H, Fisher E, Tumino R, Agnoli C, Hainaut P

Publication: PLoS One (2012) • Vol 7 • Page e39821PMID: 22808065View on PubMed

Purpose

The purpose of this paper was to determine the effects of patient characteristics, cancer progression, processing delays and extraction technique on the DNA yield from buffy coat.

Conclusion

The yield of DNA extracted from buffy coat was significantly affected by patient gender, age, body mass index (BMI), smoking status, presence of cancer, number of blood straws used for extraction, DNA extraction method, DNA quantification method, presence of hemolysis, degree of hemolysis, storage prior to refrigeration, time from refrigeration to centrifugation and current cancer diagnosis. DNA yields were not affected by time from centrifugation to freezing, time from blood collection to cancer discovery, and prior cancer diagnosis. The yield of DNA also varied significantly between the 19 centers.

Studies (1)

Purpose

The purpose of this study was to determine the effects of patient characteristics (age, BMI, gender, smoking status), timing of blood collection relative to cancer diagnosis, processing delays and extraction technique on the DNA yield from frozen buffy coat specimens. The study used a cohort of 52,256 blood specimens from 19 centers throughout Europe representing many different sub-studies on disease (cancer, heart disease, diabetes) genetics. Specimens were collected into monovette tubes containing anticoagulant (unspecified), and buffy coats were obtained by centrifugation. To each 2 mL aliquot of buffy coat, 0.5 mL of physiological solution was added, and the specimens were split and stored in straws which were stored frozen for an unspecified duration until DNA extraction.

Summary of Findings

Significantly more DNA was obtained when specimens were stored in 2 straws rather than just 1 (p<0.01), from females than males (p<0.01), from smokers than non-smokers (p<0.01), using the automated LS1 than the LS2 or manual extraction (p<0.01, both) and from specimens without visible hemolysis than those with hemolysis (p<0.01). Further, the DNA yield was higher when quantified using Picogreen than Nanodrop (p<0.01), and the authors report this difference was larger when DNA was obtained from 1 straw rather than 2. More DNA was obtained from individuals who had cancer than those without (p<0.01), but there was no associated effect of cancer type. However, there was no effect of having previously been diagnosed with cancer or being diagnosed after the blood on DNA yield. DNA yield decreased with older patient age (p<0.01) and higher levels of specimen hemolysis (p<0.01), lower BMI (p<0.01), longer time between blood draw and refrigeration (p=0.02) and longer time between refrigeration and centrifugation (p<0.02). However, DNA yield was not affected by the time from centrifugation to freezing. DNA yield varied significantly between the 19 centers (p<0.01), and this variance accounted for 16.9% of the total variance in DNA yield. Importantly, insufficient DNA yield or concentration was the main reason specimens could not be used further for genotyping.

  • Biospecimens

    FluidBuffy Coat
    FluidBlood
  • Preservation Types

    Frozen
  • Diagnoses

    Diabetes Type 2
    NeoplasticCarcinoma
    NeoplasticLymphoma
    Neoplastic
    Cardiovascular Disease
  • Platforms

    DNAFluorometry
    DNASpectrophotometry
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    PreaquisitionDiagnosis/ patient condition
    Current cancer diagnosis
    Future cancer diagnosis
    No diagnosis of cancer
    Prior cancer diagnosis
    PreaquisitionOther drugs
    Former smoker
    Non-smoker
    Smoker
    PreaquisitionPatient age
    45-49 years
    50-54 years
    55-59 years
    60-64 years
    <45 years
    >65 years
    PreaquisitionPatient body mass index
    25-27.5
    27.5-30
    30-35
    <25
    >35
    PreaquisitionPatient gender
    Female
    Male
    Biospecimen AcquisitionLocale of biospecimen collection
    19 centers throughout Europe
    Biospecimen AcquisitionTime of biospecimen collection
    After cancer diagnosis
    Prior to cancer diagnosis
    Biospecimen Aliquots and ComponentsAliquot size/volume
    1 straw
    2 straws
    Biospecimen Aliquots and ComponentsHemolysis
    Absent
    Present
    StorageStorage duration
    1-2 h
    1-3 h
    1.5-2 h
    2-6 h
    45-59 min
    5 min-1 h
    <1.5 h
    <45 min
    <5 min
    > 3 h
    >2 h
    >6 h
    Analyte Extraction and PurificationAnalyte isolation method
    Autopure LS1 DNA extraction system
    Autopure LS2 DNA extraction system
    Manual extraction
    Spectrophotometry SpecificTechnology platform
    Nanodrop
    Picogreen